About the Type 2 & MODY category
|
|
0
|
769
|
March 19, 2017
|
Long Covid high insulin resistance blues
|
|
15
|
195
|
October 28, 2024
|
Monitoring devices recommendations
|
|
2
|
71
|
October 24, 2024
|
Quick and easy pen and refillable from vial cartridge
|
|
3
|
46
|
October 17, 2024
|
Intramuscular injection of rapid insulin
|
|
4
|
72
|
October 14, 2024
|
New OTC wearable BGM coming out soon
|
|
16
|
480
|
September 28, 2024
|
Is my Dad a Type 2/have Type 2 levels?
|
|
4
|
63
|
September 11, 2024
|
Type 2 on insulin pump with Covid added
|
|
10
|
98
|
August 24, 2024
|
All about Insulin and insulin resistance at an advanced level
|
|
31
|
1044
|
March 4, 2024
|
Omnipod 5
|
|
1
|
216
|
January 11, 2024
|
Too much insulin
|
|
10
|
353
|
January 11, 2024
|
Any experience with BG monitoring watches from China?
|
|
7
|
354
|
December 20, 2023
|
Sugars high
|
|
7
|
233
|
December 29, 2023
|
Some Info on Dexcom 7 accuracy
|
|
7
|
486
|
October 26, 2023
|
I'm to undergo chemotherapy soon
|
|
11
|
362
|
October 25, 2023
|
Omnipod go
|
|
17
|
370
|
June 28, 2023
|
Issues with insulin dosing when combined with SGLT 2 inhibitors
|
|
2
|
255
|
June 19, 2023
|
Slow loss of weight over the last 28 months
|
|
22
|
562
|
April 9, 2023
|
Admelog side effects
|
|
0
|
291
|
March 25, 2023
|
Type 2 and gout
|
|
3
|
212
|
March 24, 2023
|
Medicare/Medicaid CGM coverage for Type 2s
|
|
1
|
291
|
March 4, 2023
|
A quick note on CGM comparisons: MARD not that great a measure even though best we have
|
|
0
|
360
|
March 2, 2023
|
Trulicity shortage
|
|
6
|
469
|
January 27, 2023
|
Type 2 diabetes: Insulin production more of a problem than insulin resistance?
|
|
1
|
597
|
December 25, 2022
|
Fast acting insulin
|
|
12
|
380
|
December 15, 2022
|
Non-invasive BG strip developed in Australia
|
|
14
|
789
|
April 27, 2022
|
Tough Problem - Dementia Patient - Need Suggestions
|
|
16
|
635
|
January 10, 2022
|
Overview article on MODY
|
|
1
|
373
|
December 24, 2021
|
Help With DexcomG6, NY Medicaid and Type2 Insulin Dependent
|
|
14
|
527
|
November 14, 2021
|
Once-a-week Ozempic, GLP-1 receptor agonist, now EU/US approved
|
|
8
|
2055
|
November 8, 2021
|